During its meeting yesterday, the federal cabinet decided to allow medical companies to set the price of the Coronavirus vaccines without any interference from the government.
According to details, the cabinet exempted medical companies from the Drug Pricing Policy and Drug Act 1976, which has enabled them to set arbitrary prices of imported Coronavirus vaccines.
Reports claim that the cabinet was divided in this matter as few members favored the decision while most opposed it.
They argued that paragraph 4 of Drug Pricing Policy 2018 requires the government to decide the price of medicines and the decision will allow medical companies to exploit poor people.
Note that 70 million out of 100 million citizens aged 18 and above need to be vaccinated in order to break the chain of transmission of Coronavirus in the country.
Around 65.5 million citizens of the targeted 70 million will be immunized with Coronavirus vaccines of Sinopharm, AstraZeneca, Pfizer, and CanSino Biologics under the government’s ongoing inoculation drive.
Meanwhile, the private sector has been allowed to cover the small difference of 4.5 million by importing the Coronavirus vaccines after registering them with DRAP.